Consumer Product Safety Information Act

Consumer Product Safety Information Act

The Consumer Product Safety Improvement Act of 2008 requires that every manufacturer of a product that is subject to a consumer product safety rule, ban, standard, or regulation enforced by the Consumer Product Safety Commission (CPSC) issue General Certificates of Conformance (GCC). This requirement applies to products that are imported or domestically manufactured.

Blueprint Medicines manufactures a prescription drug product that is governed under the CPSC regulations. The following Blueprint Medicines GCC certifies that the product (the child-resistant package) complies with the Poison Prevention Packaging Act requirements under 16 CFR § 1700. Please see CPSC regulations for further information.

To access this certificate, click on the link for the product below. For additional information, please contact us at CPSIA@blueprintmedicines.com.

Name Dosage Type
AYVAKIT™ avapritinib, 100 mg
avapritinib, 200 mg
avapritinib, 300 mg
Tablet